Neurovascular Devices Market - By Product, By Process, By Therapeutic Applications, By End-use & Global Forecast, 2023

Description

Neurovascular Devices Market is anticipated to depict strong growth during 2023-2032, owing to the constant technological innovations across neurovascular devices. In recent times, neurotechnologies have evolved to be more effective with closed-loop therapeutic control systems that deliver stimulation with optimal spatial resolution for better clinical outcomes.

Ongoing product launches and marketing strategies by leading market behemoths is speculated to influence the overall business landscape through the coming years. For instance, Medtronic plc in 2022, launched Medtronic Neurovascular Co-Lab Platform developed to expedite the innovation in stroke treatment and care.

Overall, the neurovascular devices industry is segmented in terms of product, process, therapeutic application, end-use, and region.

Based on the product, the neurothrombectomy devices segment will gain momentum from 2023 to 2032. The segmental growth will be attributed to the rising incidences of acute ischemic stroke globally. As per the WHO statistics, approximately 15 million people are likely to suffer from stroke each year globally. In addition, the neurothrombectomy procedure offers better outcomes and lowers the mortality rate in patients making it one of the most preferred treatments for acute ischemic stroke.

Considering the process, the neurothrombectomy procedure segment will depict over 6% CAGR between 2023-2032. Increasing product advancements offering enhanced neurothrombectomy procedures will favor segmental growth over the forecast period.

By therapeutic application, the stenosis segment was valued at over USD 567 million in 2022. Intracranial stenosis supports narrowing of a brain artery. Increasing incidences of spinal stenosis will positively stimulate segment expansion by 2032. For instance, several studies using the International Classification of Diseases codes revealed that the prevalence of spinal stenosis was between 7% and 23% in 2022.

In terms of end-user, the clinics segment is slated to exhibit over 6% CAGR through 2032. The segmental expansion would be ascribed to the growing patient influx in clinics for neurovascular illness treatments such as aneurysms and hemorrhagic strokes and cost-effective primary care. Also, several clinics are being outfitted with cutting-edge neurovascular equipment, which will fuel the market development.

Regionally, Europe neurovascular devices market held over 29.5% market share in 2022. The regional market growth would come from the rising burden of chronic neurological disorders across countries such as Germany, the UK, and France. As per a study, neurological disorders in the EU ranked third after CVDs and cancers depicting more than 13% prevalence in 2020. In addition, the presence of the leading industry participants across the region will benefit the overall industry.

Product Code: 794

Chapter 1 Methodology & Scope

1.1 Methodology
1.2 Market scope and definitions
1.3 Base estimates and working
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Neurovascular devices industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Process trends
- 2.1.4 Therapeutic application trends
- 2.1.5 End-use trends
- 2.1.6 Regional trends

Chapter 3 Neurovascular Devices Industry Insights

3.1 Industry landscape, 2018 - 2032 (USD Million)
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing number of brain aneurysm and ischemic strokes in North America
  - 3.2.1.2 Rising demand for minimally invasive surgical procedures
  - 3.2.1.3 Technological advancement in neurovascular treatments
  - 3.2.1.4 Government initiatives to modernize healthcare infrastructure across the globe
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Need for designing more effective and low-cost treatments
  - 3.2.2.2 Challenges involved in commercialization of neurovascular devices across developing and underdeveloped economies
3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By process
- 3.3.3 By therapeutic application
- 3.3.4 By end-use
3.4 COVID-19 impact analysis
3.5 Technology landscape
3.6 Supply chain analysis
3.7 Regulatory and reimbursement landscape
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of innovation leaders, 2021
- 4.3.1 Johnson & Johnson Inc
- 4.3.2 Medtronic
- 4.3.3 Stryker
- 4.3.4 Terumo Corporation
4.4 Strategy dashboard
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix

Chapter 5 Neurovascular Devices Market, By Product

5.1 Key product trends
5.2 Embolic coils
- 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.2.2 Market estimates and forecast, 2018 - 2032 (000' Units)
5.3 Carotid stents
- 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.3.2 Market estimates and forecast, 2018 - 2032 (000' Units)
5.4 Intracranial stents
- 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.4.2 Market estimates and forecast, 2018 - 2032 (000' Units)
5.5 Catheters
- 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.5.2 Market estimates and forecast, 2018 - 2032 (000' Units)
5.6 Embolic protection devices
- 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.6.2 Market estimates and forecast, 2018 - 2032 (000' Units)
5.7 Flow diverters
- 5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.7.2 Market estimates and forecast, 2018 - 2032 (000' Units)
5.8 Neurothrombectomy devices
- 5.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.8.2 Market estimates and forecast, 2018 - 2032 (000' Units)
5.9 Intrasaccular devices
- 5.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.9.2 Market estimates and forecast, 2018 - 2032 (000' Units)
5.10 Balloon systems
- 5.10.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.10.2 Market estimates and forecast, 2018 - 2032 (000' Units)
5.11 Stent retrievers
- 5.11.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.11.2 Market estimates and forecast, 2018 - 2032 (000' Units)
5.12 Guidewires
- 5.12.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.12.2 Market estimates and forecast, 2018 - 2032 (000' Units)
5.13 Others
- 5.13.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.13.2 Market estimates and forecast, 2018 - 2032 (000' Units)

Chapter 6 Neurovascular Devices Market, By Process

6.1 Key process trends
6.2 Neurothrombectomy procedure
- 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Cerebral angiography technique
- 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Carotid endarterectomy (CEA)
- 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Stenting
- 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Microsurgical clipping
- 6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.7 Coiling
- 6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.8 Flow diversion
- 6.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.9 Others
- 6.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Neurovascular Devices Market, By Therapeutic Application

7.1 Key therapeutic application trends
7.2 Brain aneurysm
- 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Stenosis
- 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Ischemic stroke
- 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Others
- 7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Neurovascular Devices Market, By End-use

8.1 Key end-use trends
8.2 Hospitals
- 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Ambulatory surgical centers
- 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Clinics
- 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.5 Others
- 8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Neurovascular Devices Market, By Region

9.1 Key regional trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 France
- 9.3.3 UK
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Russia
- 9.3.7 Turkey
- 9.3.8 Netherlands
- 9.3.9 Belgium
- 9.3.10 Austria
- 9.3.11 Switzerland
- 9.3.12 Poland
- 9.3.13 Czech Republic
- 9.3.14 Hungary
- 9.3.15 Portugal
- 9.3.16 Greece
- 9.3.17 Romania
- 9.3.18 Bulgaria
- 9.3.19 Denmark
- 9.3.20 Sweden
- 9.3.21 Norway
- 9.3.22 Finland
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Singapore,
- 9.4.7 Hong Kong
- 9.4.8 Taiwan,
- 9.4.9 Indonesia
- 9.4.10 Cambodia
- 9.4.11 Philippines
- 9.4.12 Vietnam,
- 9.4.13 Malaysia
- 9.4.14 Thailand
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 MEA
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE

Chapter 10 Company Profiles

10.1 Asahi Intecc CO., LTD.
10.2 Integer Holdings Corporation
10.3 Johnson & Johnson Services, Inc.
10.4 Kaneka Medix Corp.
10.5 LivaNova PLC
10.6 Medtronic
10.7 MicroPort Scientific Corporation
10.8 Penumbra, Inc.
10.9 Stryker
10.10 Terumo Corporation

Neurovascular Devices Market - By Product, By Process, By Therapeutic Applications, By End-use & Global Forecast, 2023 - 2032